FDA
- Status: approved
PI-based regimen (PI-based regimen) regulatory status in United States.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA has authorised it.
Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia is the originator. The local marketing authorisation holder may differ — check the official source linked above.